2nd Annual Biotech and Money New York 2016

November 2016, New York, United States

CONNECTING NEW YORK'S LIFE SCIENCE EXECUTIVES

290 EXECUTIVES

87% LIFESCIENCE, INVESTOR & PHARMA

72% CXO, VP & DIRECTOR LEVEL

PRE-REGISTER YOUR INTEREST FOR 2016

DOWNLOAD POST EVENT REPORT

LEAD PARTNER

STRATEGIC PARTNER

HOST PARTNER

2015 PARTNERS

GOLD PARTNER

SILVER PARTNER

SILVER PARTNER

2015 PARTNERS

ASSOCIATE PARTNER

ASSOCIATE PARTNER

ASSOCIATE PARTNER

2015 PARTNERS

SUPPORTING PARTNERS

2015 PARTNERS

SUPPORTING PARTNERS

2015 PARTNERS

SUPPORTING PARTNERS

2015 PARTNERS

CHANGE YOUR COMPANY'S FUNDING, INVESTMENT AND PARTNERING OUTLOOK

2nd annual Biotech and Money New York and HealthEx New York are co-located events that aim to shine
a light on New York's life science eco-system, helping promote NYC as a centre for life science excellence.

The congress provides genuine peer 2 peer knowledge sharing, networking and deal making
opportunities between life science executives to uncover new ideas to move the industry forward.

At its heart is a mission to help build linkages and business opportunities between East Coast life
science companies, capital and partners.

It's where life science meets money, investors meet deal flow and industry promote strategic
collaborations.

LEARN ABOUT B&M NEW YORK

LEARN ABOUT HEALTHEX NEW YORK

‘A lot of positive feedback! Terrific brand recognition. We also had loads of people requesting free access to the portal we’re marketing here today.’

Terence Lippert, Senior Sales Engineer, Intralinks

Nathan Tinker, CEO, NYBIO

‘The right people in the right place at the right time. New York is on the verge of exploding and this is the conference that puts all the pieces together.’

Chris Seaton, Senior Vice President of Negotiations, Bayer

‘It was a terrific meeting with a great agenda. And probably most importantly the attendee and speaker list was filled with the kind of people I need to talk to, need to meet and like to see.'

Yuval Cohen, Corbus

‘The star power – with people like Jeremy Levin, Deerfield, Spark Therapeutics etc. was a real draw. The discussions I heard were very informative - I learned quite a few new things. The networking opportunity was also really above my expectations.'

Louise Tiranoff, CEO GeneticaLens

‘I now have appointments and a great opportunity to work with a new partner on this big pilot we are planning. The learning about fund raising was also great. This was a great environment for that.’

BENEFITS TO ATTENDING

Introduce your company, your science and/or technology to
qualified, active life science investors from across the East
Coast. From Angels and crowdfunders, to Venture and
Corporate Venture Capital, private equity and debt finance.

LIFE SCIENCE EXECUTIVES

INVESTORS AND PHARMA

This congress will help you uncover untapped investment
and partnering opportunities in Rx, Dx, Medtech, Devices
and Digital Health. Meet a range of Entrepreneurs and
CEOs of private growth and publicly $bn listed businesses.

FINANCIAL SERVICES

The congress provides an opportunity for financial and
professional services to maintain existing client relations,
generate new business opportunities and make those all
important introductions with life science decision makers.

WHAT MAKES THE EVENT UNIQUE

Exclusive audience

Qualified C-level only audience.

New players

Inventors, innovators and entrepreneurs.

Online company showcases

Accessed by Investors and Pharma.

Engaging formats

No power point.

Big on interaction.

Themed sessions

Sector spotlight thematic panels.

Group discussions

Executive level peer-to-peer debate.

Roundtables

Intimate, immmersive and interactive.

1-2-1 partnering

Evaluate and arrange onsite meetings.

2015 KEYNOTE SPEAKERS INCLUDED

See
full
speaker
faculty

Marc Tessier-Lavigne
The Rockefeller University

Tom Maniatis
Columbia University
& NY Genome Center

Michael Foley
Tri-I TDI

Susan Solomon
NY Stem Cell
Foundation

Todd Sherer
Michael J Fox
Foundation for
Parkinson's Research

Judy Dunn
Roche

Barbara Sosnowski
Pfizer

Nathan Tinker
NewYorkBIO

Richard Rudnick
Biogen Idec
Bob SIlverman
Roche
Bernard Davitian
Sanofi-Genzyme
BioVentures
Brian Gallagher
SR-One
Marian Nakada
J&J Development Corp.
Misti Ushio
Harris & Harris Group
Tim Shannon
Canaan Partners
Shari Coulter Ford
Partnership Fund for
New York City
Frank Rimalovski
NYU Innovation Venture
Fund
Karen Akinsanya
MSD
William Slattery
Deerfield Management
Charlotte Hubbert
Bill & Melinda Gates
Foundation

2015 INVESTOR, FUND, BIOTECH AND PHARMA SPEAKERS FROM

Raise your corporate profile within an engaged audience of C-Level Executives.

Obvious benefits and outcomes of partnering include:

Demonstrate Thought Leadership

Educate and Share Expertise

Align your Corporate Brand

Raise Corporate Profile

Generate Brand Awareness

Generate Business Leads